General
Advarra Announces Appointment of Jeff Sidell as Chief Technology Officer
Appointment reinforces commitment to innovative, integrated technology solutions to advance clinical research.
What Is an Institutional Biosafety Committee?
An institutional biosafety committee (IBC) ensures research is conducted safely and in compliance with the NIH guidelines. Watch our video to learn the role of an IBC.
BBK Worldwide Features Advarra Executive Michele Russell-Einhorn in Diversity and Inclusion Video
This video discusses methods IRBs can implement to increase diversity and inclusion among trial participants.
Advarra Draws Record Attendance to Onsemble Conference
More than 1,500 attendees are expected at the premier clinical research technology event spanning over four days
Advarra Publishes the State of Clinical Trial Activation at Sites Report
Advarra has published a report providing actionable solutions to streamline study activation and maximize operational efficiency
Cheryl Byers and Dr. John H. Stewart Discuss Diversity, Equity and Inclusion in Cancer Research
Diversity, equity, and inclusion (DEI) in cancer research are critical to clinical research. In this episode, Advarra’s Cheryl Byers and Dr. John H. Stewart have a discussion on what is DEI, the current climate of DEI in cancer research, and considerations to improve DEI in clinical trial enrollment and retention.
The State of Clinical Trial Activation at Sites Report
View our report on actions to streamline study activaiton and maximize operational efficiency.
Advarra Announces Release of Insights Accrual Prediction Platform, A Next-Generation Accrual Prediction Solution For Clinical Trials
Insights Accrual Prediction platform leverages machine learning to accurately predict protocol accrual, strengthening clinical research success.
Advarra Acquires Bio-Optronics, Maker of Clinical Conductor TrialSuite™
Advarra today announced that it has acquired Bio-Optronics, maker of CCTrialSuite
Biosafety, Ethical, and Logistical Challenges to Pursuing a Coronavirus Vaccine at Warp Speed
The SARS-CoV-2 pandemic has impacted all aspects of society. Various government and private groups around the world are endeavoring to develop safe and effective vaccines at an unprecedented pace and scale to quell the pandemic as quickly as possible.
Advarra Announces New Gene Therapy Ready Site Network
Learn more about Advarra's new Gene Therapy Ready Site Network.
Expanding Our Global Consulting Expertise to Solve Mission-Critical Issues
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.